Medical Xpress

DECEMBER 5, 2022

Nanotechnologies have revolutionized food technology with changes to food production, manufacture, and processing that are intended to make our food safer and healthier. Phytosanitary products, processing aids, food additives, and surfaces that touch food in storage can all transfer nanoparticles that might be consumed by humans.

Allergies 75

Allergies Scientist Manufacturing Production 75

Pharmaceutical Technology

MAY 16, 2023

Juno Pharmaceuticals Canada has purchased Omega Laboratories, a specialist injectable pharmaceutical manufacturer in Canada, for an undisclosed sum. The merged entity represents one of the biggest specialist generic injectable operations in Canada with local manufacturing facilities.

Cosmetics 130

Cosmetics Allergies Manufacturing Production 130

XTalks

SEPTEMBER 8, 2020

Albany Molecular Research Inc (AMRI), a global provider of advanced drug development and manufacturing solutions, announced that they have signed a supply agreement with AstraZeneca. The company has signed on to help manufacture AstraZeneca’s COVID-19 vaccine candidate, AZD1222, intended to protect against the SARS-CoV-2 novel coronavirus.

Manufacturing 83

Manufacturing Vaccination Vaccine Allergies 83

Pharmaceutical Technology

OCTOBER 6, 2022

from the US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) to develop a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). Therapyx will develop and manufacture the IL-12-containing microspheres in the vaccine called GneX12.

Vaccination 147

Vaccination Vaccine Development Bacterium 147

XTalks

AUGUST 25, 2023

While this act is intended to make it easier for consumers with food allergies to identify potential allergens in the products they purchase, many believe it falls short. Mitigating Cross-Contamination with MenuTrinfo One of the most pertinent concerns for anyone with allergies is the potential for cross-contamination.

Allergies 98

Allergies Manufacturing Contamination Production 98

Scienmag

NOVEMBER 9, 2020

Credit: University of Ottawa Researchers from the University of Ottawa and The Ottawa Hospital have been awarded $1,050,000 million from the Canada Foundation for Innovation to support facilities for manufacturing innovative treatments and vaccines for COVID-19.

Manufacturing 95

Manufacturing Vaccination Vaccine Research 95

Pharmaceutical Technology

AUGUST 1, 2022

The company will jointly design and analyse messenger ribonucleic acid (mRNA) Covid-19 vaccines in partnership with the NIH unit National Institute of Allergy and Infectious Diseases’ Vaccine Research Center (VRC). In November last year, GreenLight and Samsung Biologics entered a collaboration agreement to manufacture mRNA Covid-19 vaccines.

Vaccination 245

Vaccination Vaccine Development RNA 245

Delveinsight

AUGUST 6, 2020

FDA turns back peanut allergy patch of DBV Technologies. A peanut allergy patch which is based on new delivery technology has hit a snag at the FDA. These antibodies defend a cell from infection by squarely preventing the pathogen’s biological activities. The agency raised no safety concerns.

Allergies 53

Allergies Vaccination Vaccine Gene Therapy 53

Drug Discovery World

JANUARY 12, 2024

Researchers in the US have discovered that a type of immune cell in the human body known to be important for allergy and other immune responses can also attack cancer. In the future, these cells could be manufactured, preserved by freezing, and then administered to patients.

Research 115

Research Immune Response Allergies Manufacturing 115

Drug Discovery World

MARCH 1, 2024

The top stories: FDA approves first medication to reduce allergic reactions The US Food and Drug Administration (FDA) has approved monoclonal antibody Xolair (omalizumab) for immunoglobulin E-mediated food allergy in some adults and children one year or older for the reduction of allergic reactions (Type I).

Drugs 52

Drugs Allergies FDA Approval Medicine 52

XTalks

APRIL 6, 2022

As a result, the company said it was switching to other oils, and food manufacturers are reviewing their recipes. Due to the sunflower oil shortage, manufacturers of products including crisps, chips and cereal bars have been forced to alter their recipes and replace sunflower oil with refined rapeseed oil.

Manufacturing 98

Manufacturing Allergies Packaging Packaging 98

Druggist

FEBRUARY 3, 2021

Based on chemical properties of the drug, fexofenadine may cause minimal to none drowsiness; however, most manufacturers list this side effect at a common frequency. . Common branded products containing cetirizine include Benadryl Allergy One a Day and Piriteze Antihistamine Allergy Relief Tablets. . £3.40. Buy on Amazon.

Allergies 52

Allergies Pharmacy Containment Branding 52

XTalks

DECEMBER 20, 2022

In the United States, we are a leading manufacturer of small-molecule injectable medicines. Register for this free webinar to learn about drug testing in humanized mouse models in two therapeutic areas: food allergy and inflammatory bowel diseases (IBD). Why is Idacio a Cost-Effective Drug?

FDA Approval 98

FDA Approval Allergies Manufacturing Clinical Trials 98

XTalks

SEPTEMBER 3, 2021

As part of a rebrand, leading contract Development and Manufacturing Organization (CDMO) Albany Molecular Research, Inc. In its early days, it became best known for the discovery and development of the active ingredient in the allergy medication Allegra. Choosing the Right CDMO for HPAPI Development & Manufacturing.

Manufacturing 98

Manufacturing Branding Allergies Development 98

pharmaphorum

JANUARY 18, 2021

For now there is little information about the Moderna vaccine reactions, other than they are centred around a specific manufacturing lot – number 041L20A – and that “fewer than 10” cases of allergic reactions were reported. million first doses of the Pfizer/BioNTech shot, mainly within 15 minutes of the injection.

Vaccination 136

Vaccination Vaccine Allergies Scientist 136

Drug Discovery World

NOVEMBER 24, 2022

The money was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The new product development contracts are part of the Antiviral Program for Pandemics (APP), which aims to accelerate the discovery, development and manufacturing of antiviral medicines. .

Development 52

Development Allergies Production Drugs 52

Clinical Trial Podcast

SEPTEMBER 26, 2022

To answer these two questions, regulatory authorities around the world require medical product manufacturers to conduct Phase I, also known as early phase clinical trials. How will the drug or device interact with the human body? And will this interaction be safe?

Clinical Trials 98

Clinical Trials Clinical Trials Trials Clinical Research 98

pharmaphorum

JANUARY 20, 2022

The Swiss subsidiary of Glenmark Pharmaceuticals and Lotus International have signed a licensing agreement whereby Glenmark will handle the manufacture and supply of Ryaltris and Lotus will take charge of commercialising the drug, subject to approval.

Allergies 72

Allergies Marketing Manufacturing Production 72

pharmaphorum

AUGUST 10, 2020

It also includes the phase 3 randomised, placebo-controlled study of Veklury conducted by the National Institute of Allergy and Infectious Diseases (NIAID). Under the terms of the agreement Pfizer will become one of several external partners who manufacture the investigational treatment for the disease.

Drugs 81

Drugs In-Vivo Contract Manufacturing In-Vitro 81

FDA Law Blog

MAY 23, 2023

Part 117, and the Food Allergy Safety, Treatment, Education and Research Act (2021). We expect to see comments urging FDA to act against the industry practice of intentionally adding sesame to foods, but it is unclear what actions FDA could take without interfering with manufacturers’ choice over the ingredients in their products.

Containment 45

Containment Contamination Compliance Manufacturing 45

pharmaphorum

JUNE 17, 2021

The plan was announced today by National Institute of Allergy and Infectious Diseases (NIAID) director and chief medical advisor Anthony Fauci, who said a key objective would be to find oral drugs that could be taken at home early on in the course of the disease. The remaining $1.2

Allergies 74

Allergies Manufacturing Development Drugs 74

XTalks

APRIL 16, 2024

Attendees will also gain firsthand insights from speakers from the Canadian Food Inspection Agency (CFIA), the US Food and Drug Administration (FDA), Food Allergy Canada, IBM Food Trust and Celiac Canada, among others, who are at the forefront of food safety and quality assurance.

Regulation 105

Regulation Compliance Allergies Manufacturing 105

Drug Discovery World

JULY 19, 2022

The clinical trial has been launched by the National Institute of Allergy and Infectious Diseases (NIAID) to evaluate an investigational vaccine to prevent infection with Nipah virus. The virus is being manufactured by pharmaceutical company Moderna and was developed in collaboration with NIAID’s Vaccine Research Center.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Vaccination 52

XTalks

MARCH 18, 2024

Moreover, this technology allows for the production of specific food ingredients, including those that contribute to the savory taste in dishes, sourness in soft drinks and essential enzymes in cheese manufacturing.

Genetic Engineering 52

Genetic Engineering Genetics Production Protein 52

Druggist

DECEMBER 28, 2020

First-generation antihistamines can also be used to help manage allergies. Most manufactures of other antihistamines available in pharmacies and shops advice to avoid taking antihistamines during pregnancy. New fexofenadine over the counter brings a broader choice to patients who seek relief from seasonal allergies.

Pharmacy 98

Pharmacy Doctors Doctor Allergies 98

pharmaphorum

AUGUST 12, 2020

“It is absurd that Trump and [Health and Human Services Secretary Alex Azar] are touting $30 per course as a good deal for the American people, in light of the consistent and ongoing support from the US government towards mRNA-1273 research, development and manufacturing.”.

Vaccination 72

Vaccination Vaccine Manufacturing Allergies 72

The Pharma Data

MARCH 31, 2022

The study, known as the COVID-19 Variant Immunologic Landscape (COVAIL) trial, is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. based in Cambridge, Massachusetts, and Moderna is manufacturing the study vaccines that will be administered.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Immune Response 52

The Pharma Data

NOVEMBER 16, 2020

and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. About the COVID-19 Prevention Network: The COVID-19 Prevention Network (CoVPN) was formed by the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S.

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

Pharmaceutical Technology

DECEMBER 16, 2022

The monoclonal antibody (mAb) CIS43LS, derived from the antibody CIS43, targets the Plasmodium falciparum circumsporozoite protein (PfCSP), and is being studied by the National Institute of Allergy and Infectious Diseases (NIAID). The company now expects to complete its submission for a BLA with the FDA by the end of the year.

Development 264

Development Drugs Vaccination Vaccine 264

The Pharma Data

MAY 27, 2022

Food and Drug Administration is providing an update on steps it has taken that will lead to millions of bottles of specialized medical infant formula to help address immediate needs for infants with certain allergies or critical health conditions. of products manufactured here for export to foreign countries. Califf, M.D. “We

Production 52

Production Manufacturing Pharmacy Cosmetics 52

XTalks

OCTOBER 20, 2021

It is suitable for people with lactose intolerance, diabetes and allergies, and contains fatty acids, vitamins and minerals that are crucial for human health. US-based Camel Culture is offering consumers camel milk as a healthier and more easily digestible solution to cow’s milk.

Protein 105

Protein Production Containment Allergies 105

Pharmaceutical Technology

FEBRUARY 3, 2023

The Janssen vaccines studied in the Imbokodo and Mosaico studies were based on the mosaic concept, where they were intentionally designed to include a broader immunogen that could be used everywhere, says Dr. Mary Marovich, director of the Vaccine Research Program at National Institute of Allergy and Infectious Diseases (NIAID).

Vaccination 293

Vaccination Vaccine Antibody Trials 293

The Pharma Data

NOVEMBER 5, 2020

is a rapidly growing generic pharmaceutical company in the United States devoted to discovery, manufacture, sale, and distribution of prescription generic pharmaceutical products. About Jubilant Cadista Pharmaceuticals Inc. Jubilant Cadista Pharmaceuticals Inc. To learn more about Jubilant Cadista, please visit our website: www.cadista.com.

Marketing 40

Marketing Generic Pharmaceutical Contract Manufacturing Manufacturing 40

XTalks

NOVEMBER 23, 2023

Undeclared Allergens in Snack Foods — The UK In the UK, several snack foods were recalled due to the presence of undeclared allergens , posing serious risks to individuals with allergies.

Contamination 103

Contamination Regulation Bacterium Allergies 103

pharmaphorum

AUGUST 12, 2020

“It is absurd that Trump and [Health and Human Services Secretary Alex Azar] are touting $30 per course as a good deal for the American people, in light of the consistent and ongoing support from the US government towards mRNA-1273 research, development and manufacturing.”.

Vaccination 52

Vaccination Vaccine Manufacturing Allergies 52

pharmaphorum

OCTOBER 1, 2021

The debut – raising upwards of £350 million from new shares – is the largest IPO for a UK biotech company since allergy drug specialist Circassia in 2014. It may also use the cash injection for “in-licensing opportunities and potential acquisitions”, according to the document.

Marketing 52

Marketing Business Development Genome Genomics 52

Drug Discovery World

JANUARY 21, 2024

Protein and RNA-based therapeutics development is a challenging multidimensional problem, accompanied by an equally challenging scalable manufacturing process. As a vaccine immunologist Kanekiyo’s primary research interests are structure-based vaccine design, viral immunity, and host-pathogen interplay.

Protein 52

Protein Vaccination Vaccine Development 52